Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

Autor: Folprecht, G. *, Gruenberger, T., Bechstein, W., Raab, H.-R., Weitz, J., Lordick, F., Hartmann, J.T., Stoehlmacher-Williams, J., Lang, H., Trarbach, T., Liersch, T., Ockert, D., Jaeger, D., Steger, U., Suedhoff, T., Rentsch, A., Köhne, C.-H.
Zdroj: In Annals of Oncology May 2014 25(5):1018-1025
Databáze: ScienceDirect